1 / 36

10 Year Experience with the Malaysian ACS & PCI Registries:

Dr. Alan Fong shares a 10-year experience with the Malaysian ACS & PCI Registries and discusses how the data collected has been translated into research and practice. This session will provide valuable insights into addressing the local disease burden and improving therapeutic protocols.

summersm
Download Presentation

10 Year Experience with the Malaysian ACS & PCI Registries:

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Joint Meeting of Coronary Revascularisation (JCR), Busan. 9-10 December 2016. Session 5: 1550hrs, Room A 10 Year Experience with the Malaysian ACS & PCI Registries: translation into research and practice Dr Alan Fong MBChB(Bristol), MRCP(UK), FRCP (Edin), FACC, FESC, FAPSIC, FNHAM, FAsCC Consultant Cardiologist, Sarawak General Hospital Heart Centre; & Head, Clinical Research Centre, Sarawak General Hospital Adjunct Professor, Swinburne University of Technology

  2. National Health and Morbidity Surveys.. (e.1986)

  3. The NCVD Registries (e.2006) http://www.acrm.org.my/ncvd/aboutUs_overview.php

  4. NCVD PCI Registry Report 2013-2014

  5. Snapshot from the Annual Report of the NCVD-ACS Registry 2011-2013 Suggested citation: W.A. Wan Azman, K.H. Sim. (Eds). Annual Report of the NCVD-ACS Registry, Year 2011-2013. Kuala Lumpur, Malaysia: National Cardiovascular Disease Database, 2015.

  6. NCVD-ACS Registry Participating Hospitals HTF HQEI HQEII HRPZ II HSB HSNZ HPP HRPB HTAA PJHUS UMMC IJN HKL HTAR HS HA Total SDP= 19 hospitals HTJ HSA *Each SDP started to contribute data at different time period HM NCVD-ACS Registry, Malaysia (2011-2013)

  7. N ACS admissions = 14,763

  8. Mean age: 58.5 (12.2) years N ACS admissions = 14,763

  9. N ACS admissions = 14,763

  10. Hypertension 65% Diabetes 46%

  11. Presence of cumulative risk factors (Percentage), NCVD-ACS Registry, 2011-2013

  12. Type of cardiac presentation for patients with ACS (%) by admission, NCVD-ACS Registry, 2006 - 2013

  13. Age group of patients by ACS stratum NCVD-ACS Registry, 2011-2013 NSTEMI

  14. Type of treatment among STEMI patients by Age Group , NCVD-ACS Registry, 2011-2013

  15. NCVD ACS In-Hospital Mortality and 30-day Follow up: 2006-2010 VS 2011-2013 Outcome at discharge is similar but 30 day outcomes improved significantly

  16. 30-day outcome is better at cardiologist centre

  17. STEMI: comparison between NCVD and TIMI developmental dataset An Asian Validation of the TIMI risk score for ST-Segment Elevation Myocardial Infarction: Results and Implications for Cardiac Care in a Developing Country. Sharmini Selvarajah, Alan Fong Yean Yip, Gunavathy Selvaraj, Jamaiyah Haniff, Cuno S.P.M. Uiterwaal, Michiel L. Bots, PLoS One 2012;7(7):e40249

  18. STEMI reperfusion strategies in UK and Malaysia Malaysia 2013 – approx. 70% lytic, approx 9% PPCI

  19. The NCVD PCI Registry…

  20. SDPs for the NCVD PCI Registry

  21. Baseline Characteristics

  22. Cardiovascular Risk Factors

  23. Coronary stent implants!

  24. Clinical outcomes

  25. Primary PCI in STEMI – with vs without transfer

  26. MySTEMI Network (Klang Valley)

  27. ... Addressing the problems >3 billion at risk

  28. A recent hit…. with global implications

  29. Regional collaboration – 2016 and beyond

  30. ACS – a patient from Marudi (~130km from Miri by road)

  31. Summary: how the NCVD has helped us…. • Systematic collection of local data important • Better understanding of the local disease burden • Strategies to improve therapeutic protocols • Addressing the evidence gap by research • Translating research into guidelines

  32. Sarawak General Hospital

More Related